“Evaluation of VTE-PREDICT risk score in patients receiving low-dose DOACs for venous thromboembolism (VTE) secondary prophylaxis ” (2024) Mediterranean Journal of Hematology and Infectious Diseases, 16(1), p. e2024047. doi:10.4084/MJHID.2024.047.